发明名称 |
POLYPEPTIDES COMPRISING A MODIFIED BACTERIOPHAGE G3P AMINO ACID SEQUENCE WITH REDUCED IMMUNOGENICITY. |
摘要 |
The invention relates to polypeptides that comprise a portion of filamentous bacteriophage gene 3 protein (g3p) sufficient to bind to and/or disaggregate amyloid, e.g., the N1-N2 portion of g3p and mutants and fragments thereof, wherein that g3p amino acid sequence has been modified through amino acid substitution to be substantially less immunogenic than the corresponding wild-type g3p amino acid sequence when used in vivo. The polypeptides of the invention retain their ability bind to and/or disaggregate amyloid. The invention relates furthermore to the use of these variant g3p- polypeptides in the treatment and/or prevention of diseases associated with misfolding or aggregation of amyloid. |
申请公布号 |
MX2015016263(A) |
申请公布日期 |
2016.04.18 |
申请号 |
MX20150016263 |
申请日期 |
2014.05.28 |
申请人 |
NEUROPHAGE PHARMACEUTICALS, INC. |
发明人 |
TIMOTHY DAVID JONES;ROBERT GEORGE EDWARD HOLGATE;FRANCIS JOSEPH CARR;RICHARD A. FISHER |
分类号 |
A61K38/16;A61K47/48;A61P25/28;C07K14/01 |
主分类号 |
A61K38/16 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|